CoronaCentral
Dashboard
Recent
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Meta-analysis
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
Mentions
Drugs
Genes or Proteins
Genetic Variation
Locations
Medical Specialties
Prevention Methods
Risk Factors
Species
Symptoms
Test Types
Transmission Types
Vaccine Types
Viral Lineages
FAQs
Feedback
Select virus of interest
Model Systems & Tools
Share
Research proposing new model systems, tools and assays to study the virus
Published and Preprint Papers
Filter
Export
Species
Title
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.
Deglycosylated RBD produced in Pichia pastoris as a low-cost sera COVID-19 diagnosis tool and a vaccine candidate.
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization.
Mouse genome rewriting and tailoring of three important disease loci.
Colloidal aggregation confounds cell-based Covid-19 antiviral screens.
bat
Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infection.
Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters.
Improved Culture Methods for Human Coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63.
Development of an efficient yeast platform for cannabigerolic acid biosynthesis.
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles.
10
15
20
25
30